Capital Bancorp vs NewtekOne
CBNK and NEWT side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CBNK and NEWT compare
Capital Bancorp is the larger company, worth 2.2 times as much as NewtekOne ($681M against $303M).
On earnings, NewtekOne is cheaper: it trades at 4.8× trailing earnings, against 12.3× for Capital Bancorp.
Capital Bancorp grew revenue faster over the last twelve months (15.1% versus 7.1% for NewtekOne).
NewtekOne keeps more of each dollar of sales as profit, with a net margin of 22.2% compared with 22.2% at Capital Bancorp.
Both pay dividends: Capital Bancorp yields 1.2% and NewtekOne 7.2%.
NewtekOne scores higher on the StockData Score (20 against 16 for Capital Bancorp), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CBNK | NEWT |
|---|---|---|
| Size and price | ||
| Market cap | $681M | $303M |
| Share price | $41.78 | $10.49 |
| Change, 1 year | 50.8% | 4.4% |
| Change, 5 years | 57.7% | −64.8% |
| Beta (5Y) | 0.17 | 1.15 |
| Employees | 459 | 109 |
| StockData Score | ||
| Total score | 16 | 20 (better) |
| Valuation score | 2 | 6 (better) |
| Growth score | 3 (better) | 2 |
| Performance score | 4 (better) | 3 |
| Health score | 4 | 5 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 12.3× | 4.8× (better) |
| P/S | 2.7× | 1.0× (better) |
| P/B | 1.6× | 0.7× (better) |
| PEG | 2.26 | 0.27 (better) |
| FCF yield | – | −244% |
| Fair value | $35.23 | $19.14 |
| Margin of safety | −18.6% | 45.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 15.1% (better) | 7.1% |
| Revenue growth, 5Y average | 12.8% | – |
| Net income growth (TTM) | 30.3% (better) | 22.7% |
| EPS growth (TTM) | 27.3% (better) | 9.5% |
| EPS growth, 5Y average | 12.8% | – |
| Profitability | ||
| Net margin | 22.2% | 22.2% (better) |
| FCF margin | – | −251% |
| Return on equity | 14.1% | 18.0% (better) |
| Financial health | ||
| Altman Z-score | 0.30 (better) | 0.21 |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Dividend yield | 1.2% | 7.2% (better) |
| Payout ratio | 14.0% | 46.6% |
| Years of dividend growth | 4 (better) | 0 |
| Buyback yield | 1.7% | – |
| Shareholder yield | 3.0% | 7.2% (better) |
| Ownership | ||
| Held by institutions | 45.4% | 55.7% |
| Held by insiders | 25.6% | 17.2% |
| Insider net buying, 12 months | $0 | $434K (better) |
| Short interest, % of float | 4.5% | – |
Go deeper
- CBNK stock overview
- CBNK income statement
- CBNK valuation and score
- NEWT stock overview
- NEWT income statement
- NEWT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.